Posts by Charlotte Bermingham

Assessing the benefits and risks of vaccinations in young people 

Stock vaccine image

Since the rollout of the COVID-19 vaccination campaign, it has been vital to monitor the impact of vaccinations on mortality. As with any vaccine, this includes assessing the protection the vaccine offers against infection and severe outcomes, but also measuring the potential side effects and adverse events. The balance of risk and benefit becomes particularly important in groups where the likelihood of severe outcomes from COVID-19 is lower, as in younger people. Here, Charlotte Bermingham discusses new ONS analysis on vaccine safety in the context of young people.  

Read more on Assessing the benefits and risks of vaccinations in young people 

Coronavirus Deaths: Understanding ONS data on mortality and vaccination status

Stock vaccine image

Throughout the pandemic the Office for National Statistics has been providing timely data and analysis of the deaths caused by Coronavirus (COVID-19). During 2021 an important part of this work is measurement of mortality by vaccination status. In this post Charlotte Bermingham explains why we use internationally-recognised methods to ensure comparability across all our releases and how the analysis so far should be interpreted.

Read more on Coronavirus Deaths: Understanding ONS data on mortality and vaccination status